Keywords: roche, zenapax, promising, asthma, swiss, drug, major

Roche's Zenapax promising for asthma

Article | 27 September 2004

Print This

Swiss drug major Roche and USA-based Protein Design Labs have signed a worldwide agreement to co-develop and commercialize the former's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in